The George Washington University Hospital
Washington D.C., District of Columbia, 20037, United States
NCT Number: NCT05374447
The investigators will compare endobronchial ultrasound transbronchial needle aspiration (EBUS-TBNA) with intranodal forceps biopsy (EBUS-IFB) as it relates to the rate of diagnosis of suspected sarcoidosis.
Looking for future studies?
Notify Me18 year–99 year
All sexes
Interventional
Not applicable
Washington D.C., District of Columbia, 20037, United States
This is prospective, single center randomized comparative study to determine the diagnostic yield and specimen quality of endobronchial ultrasound guided intranodal forceps biopsy of patients with suspected sarcoidosis based solely on imaging. This will be a single group study and will compare transbronchial needle aspiration via 19 or 21-gauge needle with intranodal forceps biopsy.
The study aims to answer a knowledge gap a as to whether the diagnostic yield and specimen quality of EBUS-TBNA with a 19G needle is less than those obtained by 1.9mm or greater intranodal forceps biopsy. The study proposed here will add to the field by further elucidating whether this procedure is beneficial for the diagnosis as it pertains to suspected sarcoidosis.
The anticipated required enrollment is 55 patients to achieve an α of 0.05 and β of 0.2. This assumes an unassisted diagnostic yield of 62.5% with standard of care EBUS-TBNA as reported in Ray et al, and a diagnostic supplementation to 80% yield with intranodal forceps biopsies.
References
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
*:
These are the characteristics that a participant must NOT have in order to be eligible to participate in the study.
Order Number Criteria
Patients with mediastinal adenopathy will undergo EBUS-IFB and EBUS-TBNA during the same procedure to compare the yield of this procedure with EBUS-TBNA alone.
Other names: EBUS-IFB
Time frame: 1 year
Diagnostic yield of EBUS-TBNA + EBUS-IFB compared to EBUS-TBNA alone
Time frame: 1 year
Duration of combined EBUS-TBNA +IFB procedure compared to TBNA alone
Time frame: 1 year
Complications of EBUS-TBNA +IFB procedure compared to TBNA alone
George Washington University
Other
Evaluating the Diagnostic Yield and Specimen Quality With Endobronchial Ultrasound-Guided Intranodal Forceps Biopsies in Patients With Mediastinal and Hilar Lymphadenopathy: A Prospective Analysis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02689050
Bronchial Neoplasms, Carcinoma, Bronchogenic
Amsterdam, North Holland, Netherlands
View Trial DetailsNCT01658280
Hemic and Lymphatic Diseases, Hilar Lymphadenopathy
Ancona, The Marches, Italy
View Trial DetailsNCT06347939
Actinomycetales Infections, Bacterial Infections
Lund, Sweden
View Trial DetailsNCT07590947
Lung Diseases, Lung Neoplasms
Alessandria, Italy
View Trial Details